Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Immunological Reviews
|
July 6, 2023
Spatiotemporally programming cytokine immunotherapies through protein engineering
Luciano Santollani, K Dane Wittrup
Soft Matter
|
October 19, 2016
Dynamic fluid-film interferometry as a predictor of bulk foam properties
John M Frostad, Daniele Tammaro, Luciano Santollani, et al.
Mabs
|
August 4, 2022
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
Sarah C Cowles, Allison Sheen, Luciano Santollani, et al.
Molecular Cancer Therapeutics
|
October 9, 2024
Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control
Jordan A Stinson, Allison Sheen, Brianna M Lax, et al.
Nature Communications
|
March 1, 2024
CD8<sup>+</sup> T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs
Joseph R Palmeri, Brianna M Lax, Joshua M Peters, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
Tregs constrain CD8<sup>+</sup> T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy
Joseph R Palmeri, Brianna M Lax, Joshua M Peters, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
CD45 sequestration lowers the signaling threshold in lymphocytes and enhances anti-tumor immunity
Lauren Duhamel, Yiming J Zhang, William Pinney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 24, 2023
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies
Brianna M Lax, Joseph R Palmeri, Emi A Lutz, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Local delivery of cell surface-targeted immunocytokines programs systemic anti-tumor immunity
Luciano Santollani, Yiming J Zhang, Laura Maiorino, et al.
Nature Biomedical Engineering
|
January 11, 2022
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Yash Agarwal, Lauren E Milling, Jason Y H Chang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Immunological Reviews
|
July 6, 2023
Spatiotemporally programming cytokine immunotherapies through protein engineering
Luciano Santollani, K Dane Wittrup
Soft Matter
|
October 19, 2016
Dynamic fluid-film interferometry as a predictor of bulk foam properties
John M Frostad, Daniele Tammaro, Luciano Santollani, et al.
Mabs
|
August 4, 2022
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
Sarah C Cowles, Allison Sheen, Luciano Santollani, et al.
Molecular Cancer Therapeutics
|
October 9, 2024
Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control
Jordan A Stinson, Allison Sheen, Brianna M Lax, et al.
Nature Communications
|
March 1, 2024
CD8<sup>+</sup> T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs
Joseph R Palmeri, Brianna M Lax, Joshua M Peters, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
Tregs constrain CD8<sup>+</sup> T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy
Joseph R Palmeri, Brianna M Lax, Joshua M Peters, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
CD45 sequestration lowers the signaling threshold in lymphocytes and enhances anti-tumor immunity
Lauren Duhamel, Yiming J Zhang, William Pinney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 24, 2023
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies
Brianna M Lax, Joseph R Palmeri, Emi A Lutz, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Local delivery of cell surface-targeted immunocytokines programs systemic anti-tumor immunity
Luciano Santollani, Yiming J Zhang, Laura Maiorino, et al.
Nature Biomedical Engineering
|
January 11, 2022
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Yash Agarwal, Lauren E Milling, Jason Y H Chang, et al.
Page
of 2